Immunotherapy Tofacitinib Can Halt Alopecia Areata Interview with:
Dr. Morton Scheinberg, MD, PhD
From Hospital Israelita Albert Einstein and Hospital AACD,
São Paulo, and
Clinica Dermatosineida, Maringa, Parana, Brazil. What is the background for this study? What are the main findings?

Response: That universal hair loss associated with a localized autoimmune reaction on the cells involved with the hair follicles can be halted with tofacitinib. What should readers take away from your report?

Response: This is an opportunity for innovative oral therapy for alopecia universalis. What recommendations do you have for future research as a result of this study?

Response: Additional real life experience and clinical trial to be done. Is there anything else you would like to add?

Response: This new therapy does not apply to baldness of endocrine origen which is more common Thank you for your contribution to the community.


Annals of Internal Medicine November 14 2016

Reversal of Alopecia Universalis by Tofacitinib: A Case Report
Morton Scheinberg, MD, PhD; Sineida Berbert Ferreira, MD

Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.

More Medical Research Interviews on

[wysija_form id=”5″]